FHTX vs STE · rev $22.6M vs P/E 25, rev $5.46B
Foghorn Therapeutics Inc (FHTX) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
FHTX currently screens at market cap $237.8M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the FHTX and STE stock pages for the full models.
Not investment advice.